CV6 Receives MHRA Approval for Novel Cancer Therapy Phase 1a Clinical Trial

14th December 2023 11:48 am

Posted by pbd-admin

CV6 Therapeutics

Belfast, UK, 14 December 2023 – CV6 Therapeutics (‘CV6’), a drug development biotechnology company that specializes in innovative small molecule therapeutics for cancer and inflammatory diseases, announces it has received approval from the UK’s medicines regulator, the MHRA, for the company’s first-in-human Phase 1a clinical trial of its lead oncology therapeutic, CV6-168, in patients with colorectal and […]

CV6 CEO Co-authors Study on Cancer Care in Ireland

25th October 2023 11:20 am

Posted by pbd-admin

CV6 Therapeutics

All-Island Study Highlights the Cancer Legacy of the Good Friday Agreement New all-island research led by Queen’s University Belfast highlights the health and economic impact of the Good Friday Agreement on cancer across the island of Ireland in the last 25 years. The work, involving researchers from Northern Ireland, Ireland, the UK and the U.S. […]

CV6 CEO Presents at ‘Agreement 25: Cancer Knows no Borders’

19th April 2023 11:13 am

Posted by pbd-admin

CV6 Therapeutics

The focus of the world was on Belfast as global political leader’s past, and present arrived in Belfast to mark the 25th anniversary of the Belfast/Good Friday Agreement. The three-day conference (17-19th April) hosted by Queens University Belfast provided a unique opportunity for reflection on the Agreement’s impact on Northern Ireland and its place on the […]

CV6 Therapeutics Secures $9.2m to Progress Novel Cancer Drug to Phase 1a Trial

2nd November 2022 10:58 am

Posted by pbd-admin

CV6 Therapeutics

Belfast, UK, 2 November 2022 – CV6 Therapeutics (‘CV6’), a drug development biotechnology company that specializes in innovative small molecule therapeutics for cancer and inflammatory diseases, announces it has secured $9.2m to progress the company’s lead oncology asset CV6-168 into a first-in-human Phase 1a clinical trial and perform further scientific development work. Investors participating in the financing […]

New Investor CV6 Partners with QUB in Major Cancer R&D Project

24th May 2016 1:18 pm

Posted by pbd-admin

CV6 Therapeutics

With support from Invest Northern Ireland, California based CV6 Therapeutics Ltd has chosen to partner with the Centre for Cancer Research and Cell Biology at Queen’s University, Belfast for a highly innovative R&D project.